Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.
Apertura Gene Therapy is a biotechnology company that treats debilitating diseases with limited options.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.
AdaptHealth is a provider of home healthcare equipment, medical supplies to the home and related services in the United States.
Hallux develops a new topical dosage form and route of administration for treating onychomycosis.
Aurion Biotechnologies is a clinical-stage biotech company.
Stellar Health empowers providers and practice staff to deliver high-quality care through real-time notifications and meaningful incentives.
Atlas Data Storage is an information technology company focused on data storage solutions.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Lomond Therapeutics creates pharmacological platforms that target escape mutations.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
ConcertoCare is a provider of at-home and comprehensive care for seniors and other adults.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications.
Perceive Pharma operates as a pharmaceutical company.
Axon Therapies develops a healthcare device with a neuromodulation approach to treat heart failure.
Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.
Actio Biosciences is a research center that develops drugs for rare diseases.
myLaurel offers in-home care, telemedicine, and extended follow-up services to reduce hospitalizations and re-admissions.
Deerfield has invested in 161 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Deerfield's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Biopharma. The firm invests across 31 different industry categories.
Among tracked funding rounds, AdaptHealth received $1.1B in a Post-IPO Debt round. Deerfield's total known invested capital is $7.3B.
Deerfield's average investment size is $65.0M across its portfolio of 161 companies.
Recent Deerfield portfolio additions include Oncorus, GH Research, Acutus Medical, Apertura Gene Therapy, Adela. These companies were founded in 2020 or later.